ArrowMark Colorado Holdings’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $223K | Hold |
|
|||||
|
2020
Q2 | $227K | Sell |
|
|||||
|
2020
Q1 | $381K | Sell |
|
|||||
|
2019
Q4 | $527K | Hold |
|
|||||
|
2019
Q3 | $368K | Sell |
|
|||||
|
2019
Q2 | $1.24M | Buy |
|
|||||
|
2019
Q1 | $1.59M | Sell |
|
|||||
|
2018
Q4 | $2.55M | Hold |
|
|||||
|
2018
Q3 | $3.06M | Hold |
|
|||||
|
2018
Q2 | $3.44M | Sell |
|
|||||
|
2018
Q1 | $4.31M | Sell |
|
|||||
|
2017
Q4 | $39.3M | Sell |
|
|||||
|
2017
Q3 | $59.2M | Sell |
|
|||||
|
2017
Q2 | $42.9M | Sell |
|
|||||
|
2017
Q1 | $31.1M | Sell |
|
|||||
|
2016
Q4 | $25.9M | Buy |
|
|||||
|
2016
Q3 | $26.5M | Buy |
|
|||||
|
2016
Q2 | $20.6M | Buy |
|
|||||
|
2016
Q1 | $19.5M | Buy |
|
|||||
|
2015
Q4 | $16.6M | Buy |
|
|||||
|
2015
Q3 | $1.41M | Buy |
|
|||||
|
2015
Q2 | $1.36M | Hold |
|
|||||
|
2015
Q1 | $1.18M | Sell |
|
|||||
|
2014
Q4 | $16.5M | Sell |
|
|||||
|
2014
Q3 | $17.3M | Sell |
|
|||||
|
2014
Q2 | $16.4M | Buy |
|
|||||
|
2014
Q1 | $8.77M | Sell |
|
|||||
|
2013
Q4 | $8.49M | Buy |
|
|||||
|
2013
Q3 | $2.24M | Sell |
|
|||||
|
2013
Q2 | $1.34M | Buy |
|